Revance Therapeutics | RVNC - Action



Action Changement Date
AbbVie USD 5.05B 98M 2026-03
ALKERMES USD 336.7M 140.08M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Cara Therapeutics USD 900K 0 2025-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 14.53B 785M 2026-03
J&J USD 14.58B 392M 2026-03
Merck USD 6.48B 179M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
P&G USD 7.85B 36M 2026-03
Pacira USD 150.37M 2.49M 2026-03
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03